Impact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional study

被引:0
作者
Jun Tsugawa
Rieko Onozawa
Jiro Fukae
Takayasu Mishima
Shinsuke Fujioka
Yoshio Tsuboi
机构
[1] Fukuoka University,Department of Neurology
来源
BMC Neurology | / 15卷
关键词
Parkinson’s disease; Quality of life; Parkinson’s disease questionnaire-8; Insufficient drug efficacy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
[1]  
Ahlskog JE(2001)Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord. 16 448-458
[2]  
Muenter MD(2006)Levodopa, motor fluctuations and dyskinesia in Parkinson’s disease Expert Opin Pharmacother. 7 1715-1730
[3]  
Müller T(2011)Available and emerging treatments for Parkinson’s disease: a review Drug Des Devel Ther. 5 241-254
[4]  
Russ H(1967)Parkinsonism: onset, progression and mortality Neurology. 17 427-42
[5]  
Hickey P(2007)Cross-cultural evaluation of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain Parkinsonism Relat Disord. 13 22-28
[6]  
Stacy M(1997)The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score Age Ageing. 26 353-357
[7]  
Hoehn MM(2005)Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment Mov Disord. 20 726-733
[8]  
Yahr MD(2005)Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations Mov Disord. 20 11-16
[9]  
Jenkinson C(2005)Impact of the motor complications of Parkinson's disease on the quality of life Mov Disord. 20 224-230
[10]  
Fitzpatrick R(2011)The impact of sleep and mood disorders on quality of life in Parkinson's disease patients J Neurol 258 2222-2229